Clinical Trial Update: IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intraperitoneal heated chemotherapy (IPHC) in platinum-sensitive recurrent ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Ovarian Epithelial Cancer Recurrent | Phase 2 | Status: COMPLETED